5-23509088-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020227.4(PRDM9):c.55G>A(p.Glu19Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000719 in 1,614,140 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020227.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PRDM9 | NM_020227.4 | c.55G>A | p.Glu19Lys | missense_variant | 2/11 | ENST00000296682.4 | |
PRDM9 | NM_001376900.1 | c.55G>A | p.Glu19Lys | missense_variant | 2/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PRDM9 | ENST00000296682.4 | c.55G>A | p.Glu19Lys | missense_variant | 2/11 | 1 | NM_020227.4 | P1 | |
PRDM9 | ENST00000502755.6 | c.55G>A | p.Glu19Lys | missense_variant | 2/11 | 4 | |||
PRDM9 | ENST00000635252.1 | c.17-832G>A | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000335 AC: 51AN: 152204Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000801 AC: 20AN: 249538Hom.: 0 AF XY: 0.0000665 AC XY: 9AN XY: 135396
GnomAD4 exome AF: 0.0000445 AC: 65AN: 1461818Hom.: 0 Cov.: 31 AF XY: 0.0000385 AC XY: 28AN XY: 727220
GnomAD4 genome AF: 0.000335 AC: 51AN: 152322Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74466
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2021 | The c.55G>A (p.E19K) alteration is located in exon 2 (coding exon 1) of the PRDM9 gene. This alteration results from a G to A substitution at nucleotide position 55, causing the glutamic acid (E) at amino acid position 19 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at